EUVIMEDEUVIMED entdecken
Crossref

Role of Lp(a) in patients with erectile dysfunction undergoing angioplasty for symptomatic pelvic artery disease

Christoph Kalka iD, Lisa Lippik, Folker Wenzel, Hanno Hoppe iD, Hak-Hong Keo, Christian Heiss iD, Nicolas Diehm

Vasa · 2023

DOI: 10.1024/0301-1526/a001072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vasa, 2023. Verfasst von Christoph Kalka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Marienhospital Bruehl, Germany. Hauptthemen laut MEDLINE: Erectile Dysfunction, Impotence, Vasculogenic, Atherosclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerotic disease of erection-related arteries is a major reason for erectile dysfunction (ED). Lp(a) has been implied in the pathophysiology of atherosclerosis in the coronary and lower limb arteries. Here, we investigated if Lp(a) plays a specific role in ED due with symptomatic pelvic artery atherosclerosis. Patients and methods: Out of 276 consecutive patients treated for ED with angioplasties on proximal (69%) and distal (31%, distal to Alcock channel) erection-related arteries, 236 patients (age: 62±10 years) of which Lp(a) values were available were retrospectively analyzed.

Results

The baseline International Index of Erectile Function-15 (IIEF-15) score was 29±15 and significantly increased to 43±20 (increase: 14±21) after treatment at average follow up of 286±201 days. In 25%, Lp(a) values were elevated to more than 30 mg/dL. Hypercholesterolemia, coronary, lower extremity peripheral, and polyvascular disease were more common in patients with Lp(a) ≥60 mg/dl. Anatomic arterial lesion distribution (proximal/distal), improvement in IIEF-15 and clinically driven re-intervention rate (overall 7%) did not differ between patients with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionImpotence, VasculogenicAtherosclerosisMaleHumansMiddle AgedAgedRetrospective StudiesAngioplastyArteries

Stichwörter der Autor:innen

Lipoprotein(a)endovascular treatmenterectile dysfunctionpenile artery

Autor:innen und Institutionen

  • Marienhospital Bruehl, Germany.
  • Faculty of Medicine, University of Cologne, Germany.
  • Vascular Institute Central Switzerland, Aarau, Switzerland.
  • University of Applied Sciences Furtwangen, Villingen-Schwenningen, Germany.
  • Faculty of Medicine, University of Lucerne, Switzerland.
  • University of Bern, Switzerland.

ORCID-Profile: Christoph Kalka, Hanno Hoppe, Christian Heiss

Zitieren

APA

Kalka, C., Lippik, L., Wenzel, F., Hoppe, H., Keo, H. H., Heiss, C., & Diehm, N. (2023). Role of Lp(a) in patients with erectile dysfunction undergoing angioplasty for symptomatic pelvic artery disease. Vasa. https://doi.org/10.1024/0301-1526/a001072

Vancouver

Kalka C, Lippik L, Wenzel F, Hoppe H, Keo HH, Heiss C, et al. Role of Lp(a) in patients with erectile dysfunction undergoing angioplasty for symptomatic pelvic artery disease. Vasa. 2023. doi:10.1024/0301-1526/a001072

BibTeX
@article{Kalka2023,
  author = {Kalka, Christoph and Lippik, Lisa and Wenzel, Folker and Hoppe, Hanno and Keo, Hak-Hong and Heiss, Christian and Diehm, Nicolas},
  title = {Role of Lp(a) in patients with erectile dysfunction undergoing angioplasty for symptomatic pelvic artery disease},
  journal = {Vasa},
  year = {2023},
  doi = {10.1024/0301-1526/a001072}
}
Kostenlos starten →